CBC News
@CBCNews·4.7M subscribers·47K videos
Ozempic reduces the risk of kidney disease complications, study finds
Posted
May 25, 2024
Views
8,587
Likes
167
Engagement
1.94%
May 25, 2024
8,587
167
1.94%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
6:25Now PlayingClinical trial data presented by manufacturer Novo Nordisk shows that Ozempic lowers the risk of complications such as kidney failure and death for people with Type 2 diabetes and chronic kidney disease.
»»» Subscribe to CBC News to watch more videos
Connect with CBC News Online:
For breaking news, video, audio and indepth coverage
Follow CBC News on TikTok
Follow CBC News on Twitter
Find CBC News on Facebook
Follow CBC News on Instagram
Subscribe to CBC News on Snapchat
Download the CBC News app for iOS
Download the CBC News app for Android
»»»»»»»»»»»»»»»»»»
For more than 80 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
